Table 5.
Cartilage homing peptides that cited the venom of T. obscurus or toxins from this species.
| Type of invention | Priority to/Priority date Publication date/publication of |
Assigned to | ICP |
|---|---|---|---|
| Cartilage-homing peptides |
EP16845226.6A/2016-09-09 WO2017044894A2/2017-03-16 WO2017044894A3/2017-05-11 |
Blaze Bioscience Inc Fred Hutchinson Cancer Center | A61K38/17 |
| Conjugates of cartilage-homing peptides |
US20210252159A1/2019-04-19 US20210252159A1/2021-08-19 |
Fred Hutchinson Cancer Center | A61K47/64 |
| Cartilage-homing peptides | EP3347035A2/2018-07-18 | Blaze Bioscience Inc Fred Hutchinson Cancer Center |
A61K49/0056 |
Abbreviations: IPC – International Patent Classification: A61: medical or veterinary science; hygiene; A61K38/17: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivaives thereof from animals; from humans; A61K47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent; A61K49/0056 - Peptides, proteins, polyamino acids.